Outcome of Pomalidomide Therapy in Relapsed /Refractory Myeloma: A Uk Multi-Centre ExperienceNicola Maciocia, Neil Rabin, Faye Sharpley et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 3
Belantamab Mafodotin Plus Cyclophosphamide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma: Interim Results from the UK Myeloma Research Alliance Prommise Clinical TrialRakesh Popat, Christopher Parrish, Ceri Bygrave et al.|Blood|2024Cited by 3